期刊文献+

门诊抗高血压药处方用药分析 被引量:1

Analysis of Outpatient Prescriptions of Antihypertensive Drugs
下载PDF
导出
摘要 目的了解本院门诊抗高血压药物的使用情况。方法采用世界卫生组织推荐的限定日剂量、药物利用指数等方法,对本院2009年1月门诊处方抗高血压药的使用情况进行统计、分析。结果各年龄组间的高血压患病率差异存在显著性,且随年龄的增长而显著增加。钙拮抗剂、血管紧张素Ⅱ受体拮抗剂(ARB)、血管紧张素转换酶抑制剂(ACEI)的使用频率最高。联合用药占全部处方40.94%,其中以二联用药为主。结论本院抗高血压药应用基本符合2005年版《中国高血压防治指南》。单药治疗以第3代钙拮抗剂、ARB、长效ACEI为主。大部分联合用药方案较合理,但也存在一些重复用药行为,应引起临床医生重视。 Objective To probe into the situation of the use of antihypertensive drugs in our hospital. Methods The use of antihypertensive drugs in our hospital during January of 2009 was analyzed statistically by using definite daily dose (DDD) and DUI recommended by WHO as indicators. Results The differences between different age group in respect of incidences of hypretension were significant and increased with the increase of age. The most frequently prescribed anti - hypertensive drugs were calcium channel blocker, Angiotensin - Ⅱ receptor antagonist and angiotensin converting enzyme inhibitor(ACEI). The rate of drug combination accounted for 40.94% of the total prescriptions, most of which were combination of two drugs. Conclusion The utilization of antihypertensive drugs in our hospital was basically in line with China Guidelines on Prevention and Management of High Blood Pressure. The Third generation calcium channel blocker, ARB and ACEI with prolonged action took the lead among the monotherapy. Most of the drug combination therapies were rational, but there were cases of repeated use of drugs, which called for great attention in the clinic.
出处 《南华大学学报(医学版)》 2010年第2期232-235,共4页 Journal of Nanhua University(Medical Edition)
关键词 抗高血压药 处方分析 限定日剂量 合理用药 药物利用 anti - hypertensive drug prescription analysis definite daily dose ( DDD ) rational drug use drug utilization
  • 相关文献

参考文献9

  • 1中国高血压防治指南修订委员会.中国高血压防治指南(2005年修版)[J].高血压杂志,2005,134(z):2-41. 被引量:4
  • 2陈新谦等主编..新编药物学 第15版[M].北京:人民卫生出版社,2003:920.
  • 3余振球等主编..高血压防治进展与实践[M].北京:科学出版社,2003:386.
  • 4Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[J].JAMA,2003,289(19):2560. 被引量:1
  • 5Volpe M,Tocci G.2007 ESH/ESC Guidelines for the management of hypertension,from theory to practice:global cardiovascular risk concept[J].J Hypertens,2009,27(Suppl 3):S3-11. 被引量:1
  • 6HeJ,GuD,WuX,et al.Major causes of death among men and women in China[J].N Engl J Med,2005,353(11):1124. 被引量:1
  • 7管弦,余江毅.糖尿病高血压的治疗[J].临床内科杂志,2004,21(10):717-719. 被引量:22
  • 8刘国仗,马文君,王兵.高血压药物治疗的现状和展望[J].中华心血管病杂志,2003,31(2):157-158. 被引量:121
  • 9Braunwald E,Domanski MJ,Fowler SE,et al.For the PEACE trial investigators.Angiotensin-converting-enzyme inhibitors in stable coronary artery disease[J].N Engl J Med,2005,353(20):2058. 被引量:1

二级参考文献16

  • 1UK Prospective Diabetes Study group: Tight blood pressure and risk of macro vascular complications in type2 diabetes:UKPDS 38. BMJ, 1998,317(7160) :703-713. 被引量:1
  • 2Hansson L, Zanchett: A, Garruthers, SSG, et al. For the HOT Study group:Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment(HOT) randomized trial. Lancet, 1998,351 (9118):1755-1762. 被引量:1
  • 3Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular outcomes in people with diabetes mellitus:results of the HOPE study and MICRO-HOPE and MICRO-HOPE Sub study Lancet,2000,355(9200) :253-259. 被引量:1
  • 4LeoN,JanL,Thomas H,et al. For the CAPPP study group. Reduced car diovascular morbidity and mortality in hypertension diabetic patients on first-line therapy with and ACE inhibitor compared with a diuretic/βblocker based treatment regimen. Diabetes Care, 2001,24 ( 12 ): 2091-2096. 被引量:1
  • 5Bjorn D,Richard BD,Severre EK,et al. For the LIFE study group. Cardiovascular morbility and mort ality in the Losartan intervention for endpoint reduction in hypertention study(LIFE) :a randomized trial against atenolol. Lancet ,2002,359 ( 9311 ) :995-1003. 被引量:1
  • 6Alkharouf J, Nalinikumari K, Cony D, et al. Long-term effects of the angiotension converting enzyme inhibitor captopril on metabolic control in non-insulin-dependent diabetes mellitus. Am J Hypertens, 1993, 6 (SPt1) :337-343. 被引量:1
  • 7Wakisaka M,Yoshinari M, Nakamura S, et al. Suppression of sodium-dependent glucose uptake by captopril improves high-glucose-induced morphological and functional changes of cultured bovine retinal percytes. Microvasc Res, 1999,58 (3): 215 -223. 被引量:1
  • 8Haithcock D ,Jiao H, Cuixl, et al. Renal proximal tubular AT2 receptor:signaling and transport. J Am Soc Nephrol, 1999,11 (suppl): S69-S74. 被引量:1
  • 9American Diabetes Association:Implications of the United Kingdom Prospective Diabetes Study. Diabetes Care,1998,21 (12) :2180-2184. 被引量:1
  • 10Patel V, Rassam SM, Chen HC, et al. Effect of angiotension converting enzyme inhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects. Metabolism, 1998,47(12 suppl 1) :2-33. 被引量:1

共引文献141

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部